Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kaoru Nishi is active.

Publication


Featured researches published by Kaoru Nishi.


Clinical and Experimental Dermatology | 2009

Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease

Satoshi Nakamura; Yoshio Hashimoto; S. Igawa; M. Kajino; Kaoru Nishi; Hidetoshi Takahashi; T. Mizumoto; Hajime Iizuka

Generalized pustular psoriasis (GPP) is a rare inflammatory variant of psoriasis, which presents as systemic inflammatory response syndrome (SIRS). Childhood GPP occasionally develops after streptococcal infection, and an association with acute cytokine response induced by tumour necrotic factor (TNF)-a has been suggested. We used ciclosporin microemulsion preconcentrate with excellent response in a case of GPP. We also analysed the cytokine levels during the disease course. An 8-year-old boy developed erythema on his buttock after upper respiratory infection in early December 2007. He was diagnosed by a local dermatologist as having erythema multiforme, and treated with topical steroid ointment, antihistamine administration, dexamethasone 1.5 mg ⁄ day and antibiotics for 2 weeks without any beneficial response. He was referred and admitted to our hospital at the end of December. On physical examination, generalized scaly erythema with numerous pustules were found (Fig. 1). The child s body weight was 38 kg and his temperature was 37.3 C. There was no personal or family history of psoriasis.


European Journal of Dermatology | 2012

Livedoid vasculopathy; favorable clinical response with low dose warfarin

Satoshi Nakamura; Mari Kishibe; Kaoru Nishi; Yoshio Hashimoto; Keiko Takeda; Toshihiro Mizumoto; Hajime Iizuka

ejd.2011.1529 Auteur(s) : Satoshi Nakamura1,2 [email protected], Mari Kishibe2, Kaoru Nishi1, Yoshio Hashimoto1, Keiko Takeda2, Toshihiro Mizumoto1, Hajime Iizuka2 1 Asahikawa Kousei Hospital, Department of Dermatology, 1-joudori 24-chome 111, Asahikawa Hokkaido, Japan 2 Asahikawa Medical University, Department of Dermatology, Asahikawa Hokkaido, Japan Livedoid vasculopathy (LV) is a chronic, recurrent, painful skin disorder involving distal lower extremities. LV is induced by coagulation [...]


American Journal of Dermatopathology | 2012

Two cases of male nipple leiomyoma: idiopathic leiomyoma and gynecomastia-associated leiomyoma.

Satoshi Nakamura; Yoshio Hashimoto; Keiko Takeda; Kaoru Nishi; Akemi Ishida-Yamamoto; Toshihiro Mizumoto; Hajime Iizuka

We describe 2 cases of male nipple leiomyoma. A 70-year-old man had a painful subcutaneous tumor on his left nipple of 6 months duration. Histopathology disclosed dermal spindle cells with oval-shaped nuclei forming interlacing bundles with irregular pattern. Glandular elements were absent. The spindle cells were positive to α-smooth muscle actin, desmin, and vimentin. Estrogen receptor (ER) and progesterone receptor (PrR) were negative. We diagnosed this case as male leiomyoma of the nipple. Another patient was a 61-year-old man with gynecomastia induced by spironolactone of 6 months duration. He also had a painful nodule on his left nipple and histopathology disclosed spindle-shaped tumor cells as in the previous patient. The tumor was accompanied by glandular elements in the deep dermis and subcutaneous tissue, which showed apocrine secretion and were positive for α-smooth muscle actin, ER, and PrR. These glandular elements were interpreted as mammary gland. But ER and PrR stain did not show positive results for leiomyoma in the upper dermis. To the best of our knowledge, this is the first report of male idiopathic and gynecomastia-induced leiomyoma with ER and PrR staining.


Journal of Dermatological Treatment | 2012

Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis

Satoshi Nakamura; Keiko Takeda; Yoshio Hashimoto; Kaoru Nishi; Hidetoshi Takahashi; Toshihiro Mizumoto; Hajime Iizuka

Abstract Although ciclosporin is useful for atopic dermatitis (AD), appropriate dosage and therapeutic drug monitoring (TDM) has been performed only by post-prandial ciclosporin administration. We administered ciclosporin pre-prandially to eight severe adult AD patients (four cases of erythrodermic AD, three cases of AD recalcitrant to standard therapy, and one AD case with numerous pruriginous lesions). Blood concentrations of ciclosporin at various dosages were measured and appropriate dosage in terms of therapeutic efficacy was analyzed by using the area under the concentration curve (AUC). AUC was estimated by the C1 (obtained serum concentration of ciclosporin at 1 hour after ciclosporin administration), C2 (concentration of ciclosporin at 2 hours) and C4 (concentration of ciclosporin at 4 hours) concentrations of ciclosporin. The trough levels of ciclosporin with 200 mg/day, 150 mg/day, and 100 mg/day administration were 96.5 ng/ml, 66.4 ng/ml, and 75.3 ng/ml, respectively. The peak serum concentration (Cmax) was obtained at 1 hour (C1) in most cases. The AUC of 0–4 hours (AUC 0–4) were 2099.5 ng · h/ml (200 mg/day), 1782.6 ng · h/ml (150 mg/day) and 1696.2 ng · h/ml (100 mg/day). VAS scores of itching and blood eosinophil counts were decreased significantly by the ciclosporin treatment. Pre-prandial administration of a relatively low dose of ciclosporin for severe atopic dermatitis resulted in a favorable subjective and objective clinical response and the measurement of blood concentration mostly correlated with the effective dosage assessment.


Australasian Journal of Dermatology | 2012

Cutaneous tuberculosis simulating lymphocutaneous sporotrichosis

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Hidetoshi Takahashi; Keiko Takeda; Toshihiro Mizumoto; Hajime Iizuka

1. Geissler S, Dyall-Smith D, Coras B et al. Unique brown star shape on dermatoscopy of generalized Dowling–Degos disease. Australas. J. Dermatol. 2011; 52: 151–3. 2. Ackerman AB. Focal acantholytic dyskeratosis. Arch. Dermatol. 1972; 106: 702–6. 3. Ackerman AB, Chongchitnant N, Sanchez J et al. Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis, 2nd edn. Baltimore, MD: Williams and Wilkins, 1997; 421–9. 807–9. 4. Zalaudek I, Kreusch J, Giacomel J et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Non-melanocytic skin tumors. J. Am. Acad. Dermatol. 2010; 63: 377–86. 5. Vázquez-López F, Lopez-Escobar M, Maldonado-Seral C et al. The handheld dermoscope improves the recognition of giant pseudocomedones in Darier’s disease. J. Am. Acad. Dermatol. 2004; 50: 454–5.


Acta Dermato-venereologica | 2012

Cutaneous Lymphangitis Carcinomatosis Metastasis of Extra-ovarian Primary Peritoneal Carcinoma

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Toshihiro Mizumoto; Hidetoshi Takahashi; Hajime Iizuka

© 2012 The Authors. doi: 10.2340/00015555-1450 Journal Compilation


Journal of Dermatology | 2015

Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation.

Chiaki Takahashi; Kaoru Nishi; Masako Minami-Hori; Mari Kishibe; Akemi Ishida-Yamamoto; Hajime Iizuka

1 Zembowicz A, Kafanas A. Syringotropic melanoma: a variant of melanoma with prominent involvement of eccrine apparatus and risk of deep dermal invasion. Am J Dermatopathol 2012; 34: 151–156. 2 Kiryu H, Imayama S. Malignant melanoma cells in the eccrine apparatus. J Dermatol 2001; 28: 91–94. 3 Massi G, Vellone VG, Pagliarello C, Fabrizi G. Plantar melanoma that mimics melanocytic nevi: a report of 4 cases with lymph node metastases and with review of positive and negative controls. Am J Dermatopathol 2009; 31: 117–131. 4 Balch CM, Buzaid AC, Atkins MB et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000; 88: 1484–1491.


Journal of Dermatological Case Reports | 2014

Clinical response of acneiform eruptions caused by cetuximab to administration of oral tetracycline and topical ketoconazole.

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Tosihiro Mizumoto; Hidetoshi Takahashi; Hajime Iizuka

BACKGROUND Cutaneous adverse events associated with the use of epidermal growth factor receptor inhibitors, such as cetuximab are relatively common. Although there are reports about possible treatments for acne or acneiform lesions induced by cetuximab, there are only few reports of prospective studies. OBJECTIVE The aim of the study was to analyze the efficacy of varius treatment modalities and their combinations in patients with acneiform eruptions caused by cetuximab. PATIENTS AND METHODS We studied 14 patients treated with an epidermal growth factor receptor inhibitors, including 7 patients cetuximab, who developed acneiform eruptions in the course of therapy. All patients were diagnosed as grade II according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.0. A corticosteroid ointment, tacrolimus ointment, and ketoconazole ointment were used in a randomized manner. Oral therapy included administration of antihistaminic drugs, tetracycline, a cyclooxygenase inhibitor, or a macrolide. We measured the numer of days required to achieve improvement from grade II to grade I during cetuximab treatment. RESULTS Our results showed that tetracycline treatment may shorten the period needed to achieve improvement. Ketoconazole cream and a combination of oral tetracycline and topical ketoconazole also significantly shortened this period. CONCLUSION The results of our short case study may indicate that a combitation therapy of oral tetracyclin and topical ketokonazole is most effective in the therapy of patients with acneiform eruptions caused by cetuximab.


Journal of Medical Case Reports | 2014

High rate of cardiac sarcoidosis presenting with cutaneous plaque type sarcoidosis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography: a case series

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Keiko Takeda; Toshihiro Mizumoto; Toshio Demitsu; Hajime Iizuka


European Journal of Dermatology | 2012

Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Toshihiro Mizumoto; Hidetoshi Takahashi; Hajime Iizuka

Collaboration


Dive into the Kaoru Nishi's collaboration.

Top Co-Authors

Avatar

Hajime Iizuka

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiko Takeda

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mari Kishibe

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Chiaki Takahashi

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Masako Minami-Hori

Asahikawa Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge